List of Protonix drug patents

Protonix is owned by Wyeth Pharms.

Protonix contains Pantoprazole Sodium.

Protonix has a total of 8 drug patents out of which 0 drug patents have expired.

Protonix was authorised for market use on 14 November, 2007.

Protonix is available in for suspension, delayed release;oral dosage forms.

Protonix can be used as erosive esophagitis, hypersecretory conditions including zollinger-ellison syndrome, maintenance of healing of erosive esophagitis and reduction of symptoms in patients with gerd.

The generics of Protonix are possible to be released after 07 December, 2026.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7550153 WYETH PHARMS Pantoprazole multiparticulate formulations
Sep, 2024

(1 year, 7 months from now)

US7553498 WYETH PHARMS Pantoprazole multiparticulate formulations
Sep, 2024

(1 year, 7 months from now)

US7838027 WYETH PHARMS Pantoprazole multiparticulate formulations
Sep, 2024

(1 year, 7 months from now)

US7553498

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations
Mar, 2025

(2 years from now)

US7838027

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations
Mar, 2025

(2 years from now)

US7550153

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations
Mar, 2025

(2 years from now)

US7544370 WYETH PHARMS Pantoprazole multiparticulate formulations
Jun, 2026

(3 years from now)

US7544370

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations
Dec, 2026

(3 years from now)

Drugs and Companies using PANTOPRAZOLE SODIUM ingredient

Market Authorisation Date: 14 November, 2007

Treatment: Erosive esophagitis, hypersecretory conditions including zollinger-ellison syndrome, maintenance of healing of erosive esophagitis and reduction of symptoms in patients with gerd

Dosage: FOR SUSPENSION, DELAYED RELEASE;ORAL

How can I launch a generic of PROTONIX before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic